Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
This study is currently recruiting participants.
Verified November 2012 by City of Hope Medical Center
Sponsor:
City of Hope Medical Center
Collaborators:
Merck
Information provided by (Responsible Party):
City of Hope Medical Center
ClinicalTrials.gov Identifier:
NCT00720876
First received: July 22, 2008
Last updated: November 8, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |